HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoliang Yan Selected Research

Xiaoliang Yan Research Topics

Disease

3Neoplasms (Cancer)
02/2013 - 08/2005
2Inflammation (Inflammations)
04/2022 - 01/2019
2Infections
10/2020 - 01/2020
1Diabetes Mellitus
04/2022
1Cardiomegaly (Heart Hypertrophy)
04/2022
1Hypertrophy
04/2022
1Obesity
04/2022
1Tuberculosis (Tuberculoses)
07/2019
1Triple Negative Breast Neoplasms
02/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
04/2022 - 10/2010
3Peptides (Polypeptides)IBA
10/2020 - 10/2010
2AntigensIBA
10/2020 - 07/2019
2ErbB Receptors (EGF Receptor)IBA
02/2013 - 10/2010
2Phosphotransferases (Kinase)IBA
02/2013 - 10/2010
2Tyrosine Kinase InhibitorsIBA
02/2013 - 10/2010
1Brain Natriuretic Peptide (Natrecor)FDA Link
04/2022
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
04/2022
1ResistinIBA
04/2022
1Toll-Like Receptor 4IBA
04/2022
1Atrial Natriuretic Factor (ANF)IBA
04/2022
1Messenger RNA (mRNA)IBA
04/2022
1EpitopesIBA
10/2020
1Protein Subunit VaccinesIBA
10/2020
1VaccinesIBA
10/2020
1SolutionsIBA
10/2020
1Virulence Factors (Pathogenicity Factors)IBA
01/2020
1ribokinaseIBA
07/2019
1Indicators and Reagents (Reagents)IBA
07/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Imatinib Mesylate (Gleevec)FDA Link
10/2010
1Dasatinib (BMS 354825)FDA Link
10/2010
1bcr-abl Fusion ProteinsIBA
10/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2010
1HydrogelsIBA
10/2010
1Pharmaceutical PreparationsIBA
10/2010
1polyacrylamideIBA
10/2010
1poly(acrylic acid-co-methyl methacrylate)IBA
08/2005

Therapy/Procedure

2Therapeutics
02/2013 - 10/2010
1Drug Therapy (Chemotherapy)
08/2005